Anfield Capital Management, LLC Oncternal Therapeutics, Inc. Transaction History

Anfield Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$3.37 - $4.76 $6,180 - $8,729	-1,834 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$4.75 - $9.39 $8,711 - $17,221	1,834 New	1,834 $9,000
Q1 2020 May 07, 2020	SELL	$2.49 - $4.39 $4,566 - $8,051	-1,834 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$3.75 - $6.11 $6,877 - $11,205	1,834 New	1,834 $8,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Anfield Capital Management, LLC with notifications on news.